-
Something wrong with this record ?
ROCK1 translocates from non-caveolar to caveolar regions upon KCl stimulation in airway smooth muscle
B. Sommer, L. M. Montaño, J. Chávez, V. Carbajal, L. M. García-Hernandez, C. Irles, A. M. Jiménez-Garduño, A. Ortega
Language English Country Czech Republic
Document type Journal Article, Research Support, N.I.H., Extramural
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Muscle Relaxants, Central pharmacology MeSH
- Potassium Chloride pharmacology MeSH
- Muscle, Smooth drug effects metabolism MeSH
- Caveolae drug effects metabolism MeSH
- rho-Associated Kinases metabolism MeSH
- Organ Culture Techniques MeSH
- Cattle MeSH
- Muscle Contraction drug effects physiology MeSH
- Trachea drug effects metabolism MeSH
- Protein Transport drug effects physiology MeSH
- Animals MeSH
- Check Tag
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, N.I.H., Extramural MeSH
Airway smooth muscle (ASM) membrane depolarization through KCl opens L-type voltage dependent Ca2+ channels (Ca(v)1.2); its opening was considered the cause of KCl contraction. This substance is used to bypass intracellular second messenger pathways. It is now clear that KCl also activates RhoA/Rho kinase (ROCK) pathway. ROCK isoforms are characterized as ROCK1 and ROCK2. Because ROCK1 seems the most abundant isotype in lung, we studied its participation in KCl stimulated bovine ASM. With methyl-beta-cyclodextrin (MbetaCD) we disrupted caveolae, a membrane compartment considered as the RhoA/ROCK assembly site, and found that KCl contraction was reduced to the same extent (~26%) as Y-27632 (ROCK inhibitor) treated tissues. We confirmed that KCl induces ROCK activation and this effect was annulled by Y-27632 or MbetaCD. In isolated plasmalemma, ROCK1 was localized in non-caveolar membrane fractions in Western blots from control tissues, but it transferred to caveolae in samples from tissues stimulated with KCl. Ca(v)1.2 was found at the non-caveolar membrane fractions in control and MbetaCD treated tissues. In MbetaCD treated tissues stimulated with KCl, contraction was abolished by nifedipine; only the response to Ca(v)1.2 opening remained as the ROCK component disappeared. Our results show that, in ASM, the KCl contraction involves the translocation of ROCK1 from non-caveolar to caveolar regions and that the proper physiological response depends on this translocation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15003901
- 003
- CZ-PrNML
- 005
- 20150129103452.0
- 007
- ta
- 008
- 150128s2014 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932545 $2 doi
- 035 __
- $a (PubMed)24397803
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Sommer, B. $u Department of Bronchial Hyperreactivity Research, National Institute of Respiratory Diseases, Mexico City, Mexico
- 245 10
- $a ROCK1 translocates from non-caveolar to caveolar regions upon KCl stimulation in airway smooth muscle / $c B. Sommer, L. M. Montaño, J. Chávez, V. Carbajal, L. M. García-Hernandez, C. Irles, A. M. Jiménez-Garduño, A. Ortega
- 520 9_
- $a Airway smooth muscle (ASM) membrane depolarization through KCl opens L-type voltage dependent Ca2+ channels (Ca(v)1.2); its opening was considered the cause of KCl contraction. This substance is used to bypass intracellular second messenger pathways. It is now clear that KCl also activates RhoA/Rho kinase (ROCK) pathway. ROCK isoforms are characterized as ROCK1 and ROCK2. Because ROCK1 seems the most abundant isotype in lung, we studied its participation in KCl stimulated bovine ASM. With methyl-beta-cyclodextrin (MbetaCD) we disrupted caveolae, a membrane compartment considered as the RhoA/ROCK assembly site, and found that KCl contraction was reduced to the same extent (~26%) as Y-27632 (ROCK inhibitor) treated tissues. We confirmed that KCl induces ROCK activation and this effect was annulled by Y-27632 or MbetaCD. In isolated plasmalemma, ROCK1 was localized in non-caveolar membrane fractions in Western blots from control tissues, but it transferred to caveolae in samples from tissues stimulated with KCl. Ca(v)1.2 was found at the non-caveolar membrane fractions in control and MbetaCD treated tissues. In MbetaCD treated tissues stimulated with KCl, contraction was abolished by nifedipine; only the response to Ca(v)1.2 opening remained as the ROCK component disappeared. Our results show that, in ASM, the KCl contraction involves the translocation of ROCK1 from non-caveolar to caveolar regions and that the proper physiological response depends on this translocation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a kaveoly $x účinky léků $x metabolismus $7 D021941
- 650 _2
- $a svalová kontrakce $x účinky léků $x fyziologie $7 D009119
- 650 _2
- $a centrálně působící myorelaxancia $x farmakologie $7 D009125
- 650 _2
- $a hladké svalstvo $x účinky léků $x metabolismus $7 D009130
- 650 _2
- $a orgánové kultury - kultivační techniky $7 D009924
- 650 _2
- $a chlorid draselný $x farmakologie $7 D011189
- 650 _2
- $a transport proteinů $x účinky léků $x fyziologie $7 D021381
- 650 _2
- $a trachea $x účinky léků $x metabolismus $7 D014132
- 650 _2
- $a kinázy asociované s rho $x metabolismus $7 D054460
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Montaño, L. M. $u Department of Pharmacology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico,
- 700 1_
- $a Chávez, J. $u Department of Bronchial Hyperreactivity Research, National Institute of Respiratory Diseases, Mexico City, Mexico
- 700 1_
- $a Carbajal, V. $u Department of Bronchial Hyperreactivity Research, National Institute of Respiratory Diseases, Mexico City, Mexico
- 700 1_
- $a García-Hernandez, L. M. $u Department of Pharmacology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico,
- 700 1_
- $a Irles, C. $u Department of Physiology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico
- 700 1_
- $a Jiménez-Garduño, A. M. $u Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico
- 700 1_
- $a Ortega, A. $u Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, č. 2 (2014), s. 179-187
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20150128 $b ABA008
- 991 __
- $a 20150129103646 $b ABA008
- 999 __
- $a ok $b bmc $g 1060961 $s 886656
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 63 $c 2 $d 179-187 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20150128
